Tags

Type your tag names separated by a space and hit enter

Cryosurgery of eyelid basal cell carcinomas.
Acta Ophthalmol (Copenh). 1990 Jun; 68(3):241-5.AO

Abstract

One hundred and twenty-one patients have been treated for eye lid basal cell carcinomas with cryosurgery during the last 7 years. The condition resolved completely after treatment in all patients with no recurrences observed so far. Most patients have been followed for more than 2 years. Complications were few and minor. In 14 cases conjunctival overgrowth was noted. We conclude that this treatment modality is excellent, cost-effective and easily tolerated as compared with other methods.

Authors+Show Affiliations

Gunnarson G
Department of Ophthalmology, University of Gothenburg, Sweden.
Larkö O
No affiliation info available
Hersle K
No affiliation info available

MeSH

AdultAgedAged, 80 and overCarcinoma, Basal CellCryosurgeryEyelashesEyelid NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedPostoperative ComplicationsPrognosis

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2392897

Citation

Gunnarson, G, et al. "Cryosurgery of Eyelid Basal Cell Carcinomas." Acta Ophthalmologica, vol. 68, no. 3, 1990, pp. 241-5.
Gunnarson G, Larkö O, Hersle K. Cryosurgery of eyelid basal cell carcinomas. Acta Ophthalmol (Copenh). 1990;68(3):241-5.
Gunnarson, G., Larkö, O., & Hersle, K. (1990). Cryosurgery of eyelid basal cell carcinomas. Acta Ophthalmologica, 68(3), 241-5.
Gunnarson G, Larkö O, Hersle K. Cryosurgery of Eyelid Basal Cell Carcinomas. Acta Ophthalmol (Copenh). 1990;68(3):241-5. PubMed PMID: 2392897.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cryosurgery of eyelid basal cell carcinomas. AU - Gunnarson,G, AU - Larkö,O, AU - Hersle,K, PY - 1990/6/1/pubmed PY - 1990/6/1/medline PY - 1990/6/1/entrez SP - 241 EP - 5 JF - Acta ophthalmologica JO - Acta Ophthalmol (Copenh) VL - 68 IS - 3 N2 - One hundred and twenty-one patients have been treated for eye lid basal cell carcinomas with cryosurgery during the last 7 years. The condition resolved completely after treatment in all patients with no recurrences observed so far. Most patients have been followed for more than 2 years. Complications were few and minor. In 14 cases conjunctival overgrowth was noted. We conclude that this treatment modality is excellent, cost-effective and easily tolerated as compared with other methods. SN - 0001-639X UR - https://www.unboundmedicine.com/medline/citation/2392897/Cryosurgery_of_eyelid_basal_cell_carcinomas_ DB - PRIME DP - Unbound Medicine ER -